Literature DB >> 8137158

Dopamine agonists and stress produce different patterns of Fos-like immunoreactivity in the lateral habenula.

D Wirtshafter1, K E Asin, M R Pitzer.   

Abstract

In rats treated systemically with either amphetamine, amfonelic acid or apomorphine, large numbers of cells displaying Fos-like immunoreactivity (FLI) could be seen in the lateral zone of the lateral habenula. The induction of FLI by amphetamine could be blocked either by pretreatment with haloperidol or by 6-hydroxydopamine lesions of ascending dopamine fibers at the level of the lateral hypothalamus. In contrast, a variety of stressors selectively induced FLI in the most medial portion of the lateral habenula. These findings support the concept of a functional differentiation of the medial and lateral regions of the lateral habenula and provide further evidence for involvement of the habenula in the circuitry of the basal ganglia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8137158     DOI: 10.1016/0006-8993(94)91517-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  40 in total

1.  Habenula volume in bipolar disorder and major depressive disorder: a high-resolution magnetic resonance imaging study.

Authors:  Jonathan B Savitz; Allison C Nugent; Wendy Bogers; Jonathan P Roiser; Earle E Bain; Alexander Neumeister; Carlos A Zarate; Husseini K Manji; Dara M Cannon; Sean Marrett; Fritz Henn; Dennis S Charney; Wayne C Drevets
Journal:  Biol Psychiatry       Date:  2010-11-20       Impact factor: 13.382

2.  βCaMKII in lateral habenula mediates core symptoms of depression.

Authors:  Kun Li; Tao Zhou; Lujian Liao; Zhongfei Yang; Catherine Wong; Fritz Henn; Roberto Malinow; John R Yates; Hailan Hu
Journal:  Science       Date:  2013-08-30       Impact factor: 47.728

Review 3.  Reward processing by the lateral habenula in normal and depressive behaviors.

Authors:  Christophe D Proulx; Okihide Hikosaka; Roberto Malinow
Journal:  Nat Neurosci       Date:  2014-09       Impact factor: 24.884

4.  c-Fos expression in the brains of behaviorally "split" hamsters in constant light: calling attention to a dorsolateral region of the suprachiasmatic nucleus and the medial division of the lateral habenula.

Authors:  Mahboubeh Tavakoli-Nezhad; William J Schwartz
Journal:  J Biol Rhythms       Date:  2005-10       Impact factor: 3.182

5.  Lesions of the habenula produce stress- and dopamine-dependent alterations in prepulse inhibition and locomotion.

Authors:  Scott A Heldt; Kerry J Ressler
Journal:  Brain Res       Date:  2006-01-24       Impact factor: 3.252

6.  The Lateral Habenula Directs Coping Styles Under Conditions of Stress via Recruitment of the Endocannabinoid System.

Authors:  Anthony L Berger; Angela M Henricks; Janelle M Lugo; Hayden R Wright; Collin R Warrick; Martin A Sticht; Maria Morena; Itziar Bonilla; Sarah A Laredo; Rebecca M Craft; Loren H Parsons; Pedro R Grandes; Cecilia J Hillard; Matthew N Hill; Ryan J McLaughlin
Journal:  Biol Psychiatry       Date:  2018-05-08       Impact factor: 13.382

Review 7.  Drugs of abuse and immediate-early genes in the forebrain.

Authors:  R E Harlan; M M Garcia
Journal:  Mol Neurobiol       Date:  1998-06       Impact factor: 5.590

8.  Psychostimulant-induced Fos protein expression in the thalamic paraventricular nucleus.

Authors:  A Y Deutch; M Bubser; C D Young
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

9.  Differential effects of pair housing on voluntary nicotine consumption: a comparison between male and female adolescent rats.

Authors:  Hyunchan Lee; Minji Jang; Woonhee Kim; Jihyun Noh
Journal:  Psychopharmacology (Berl)       Date:  2017-05-15       Impact factor: 4.530

10.  Inhibition of AMPA receptor and CaMKII activity in the lateral habenula reduces depressive-like behavior and alcohol intake in rats.

Authors:  Jing Li; Seungwoo Kang; Rao Fu; Liangzhi Wu; Wei Wu; Hongwei Liu; Danielle Gregor; Wanhong Zuo; Alex Bekker; Jiang-Hong Ye
Journal:  Neuropharmacology       Date:  2017-08-31       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.